DNA :: New method of selecting DNA for resequencing accelerates discovery of subtle DNA variations

A new technology developed by scientists at Emory University will allow researchers to more easily discover subtle and overlooked genetic variations that may have serious consequences for health and disease. Called Microarray-based Genomic Selection (MGS), the research protocol allows scientists to extract and enrich specific large-sized DNA regions, then compare genetic variation among individuals using DNA resequencing methods.

Obesity :: Genes may make some people more motivated to eat, perhaps overeat

Science has found one likely contributor to the way that some folks eat to live and others live to eat. Researchers at the University at Buffalo, The State University of New York, have found that people with genetically lower dopamine, a neurotransmitter that helps make behaviors and substances more rewarding, find food to be more reinforcing than people without that genotype. In short, they are more motivated to eat and they eat more.

Irritable Bowel Syndrome :: Bifantis can claim efficacy vs. placebo for IBS symptoms

A new analysis of randomized controlled trials evaluating probiotics in the treatment of irritable bowel syndrome (IBS) has found that Bifantis®, Bifidobacterium infantis 35624, the sole ingredient in Align® (manufactured by Procter & Gamble), is the only probiotic currently able to demonstrate significant improvement in IBS symptoms based upon a properly designed research study.

Alzheimer’s Disease :: New blood test to diagnose Alzheimer’s Disease

A team of international researchers reported they have identified a group of cell-signaling proteins found in blood that serve as a unique “voiceprint” that can not only be used to diagnose Alzheimer’s disease, but also classify and predict presymptomatic individuals who will eventually develop the memory-robbing disorder.

Obesity :: 1 in 5 bariatric surgery candidates not psychologically cleared for surgery

A new study by Rhode Island Hospital and Brown University researchers reported that 18 percent of 500 candidates for bariatric surgery did not receive the initial psychiatry clearance for the surgery. The study is the first to examine the reliability of decisions to clear candidates for surgery, and the largest to determine the percentage of candidates who are not cleared, and detail the reasons for exclusion.

HIV :: FDA approves Merck’s Isentress, raltegravir tablets for HIV AIDS

Merck & Co., Inc., announced that the U.S. Food and Drug Administration (FDA) granted ISENTRESS TM (raltegravir) tablets accelerated approval for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack